Galectin‐3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGF<i>β</i>1‐induced macrophages
Camila Maria Longo Machado(Universidade de São Paulo), Roger Chammas(Instituto do Câncer do Estado de São Paulo), Suely Nonogaki(Instituto Adolfo Lutz), Emerson Soares Bernardes(Instituto de Pesquisas Energéticas e Nucleares), Anamaria A. Camargo(Ludwig Cancer Research), Camila Morais Melo(Universidade de São Paulo), Verônica R. Teixeira(Universidade de São Paulo), Fabrício F. Costa(Northwestern University), Fu‐Tong Liu(University of California, Davis), Sofia Nascimento dos Santos(Instituto de Pesquisas Energéticas e Nucleares), Luciana Nogueira de Sousa Andrade(Universidade de São Paulo)
Cited by 48
Related Papers
Galectins: structure, function and therapeutic potential
|Expert Reviews in Molecular Medicine|2008|861
Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?
|Trends in Immunology|2002|530
CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens
|Nucleic Acids Research|2008|440
Galectin-3 Deficiency Reduces the Severity of Experimental Autoimmune Encephalomyelitis
|The Journal of Immunology|2009|187
Toxoplasma gondii Infection Reveals a Novel Regulatory Role for Galectin-3 in the Interface of Innate and Adaptive Immunity
|American Journal Of Pathology|2006|142